Sophiris Bio, Inc. (SPHS) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
LovingGeneva LovingGeneva 07/26/2016 1 Year $6.20 $2.85 -54% -54 Active
Comments: $SPHS $12, Oppenheimer helping for BO or partnerships, CEO Woods comments bullish, no competitor
panthers87 panthers87 06/30/2016 3 months $2.11 $3.30 +56.4% 56 Ended
badorikum badorikum 09/20/2015 3 months $1.02 $1.73 +69.61% 69 Ended
laurvp laurvp 05/22/2015 1 month $0.85 $0.96 +13.61% 13 Ended
LukaszZ LukaszZ 04/14/2015 3 months $0.80 $0.78 -3.08% -3 Ended
MarSarAsh MarSarAsh 03/18/2014 3 months $3.53 $2.48 -29.75% -29 Ended
Comments: Will get sympathy upside from NYMX move bc of almost identical drugs for BPH
Forde Forde 03/18/2014 1 Year $3.55 $0.54 -84.79% -84 Ended
Comments: Im bullish because the drug has lots of upside and limited downside

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.